Myriad Genetics Q4 Profit Tops Estimate; Guides FY15 EPS Below Consensus

(RTTNews) - Myriad Genetics, Inc. (MYGN) reported net income for the fourth quarter of $33.6 million or $0.43 per share, compared to $44.1 million or $0.53 per share for the year-ago quarter.

Excluding items, adjusted net income for the latest quarter was $37.1 million or $0.48 per share.

Revenue for the fourth quarter rose 8.4% to $188.8 million from $174.1 million a year ago.

Analysts polled by Thomson Reuters expected the company to earn $0.46 per share on revenue of $187.68 million for the fourth quatter. Analyst' estimates typically exclude special items.

Looking forward to the fiscal year 2015, the company forecasts total revenue of $800 million to $820 million, earnings of of $1.75 to $1.85 per share and adjusted earnings of $1.90 to $2.00 per share. Analysts currently expect the company to earn $2.39 per share on revenue of $776.59 million for the fiscal year 2015.